About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 402369, 8 pages
http://dx.doi.org/10.1155/2013/402369
Review Article

Development of Multiexon Skipping Antisense Oligonucleotide Therapy for Duchenne Muscular Dystrophy

1Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford OX1 3QX, UK
2Department of Medical Genetics, School of Human Development, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada T6G 2H7
3The Friends of Garrett Cumming Research and Muscular Dystrophy Canada HM Toupin Neurological Science Research Chair, University of Alberta, Edmonton, AB, Canada T6G 2H7

Received 30 April 2013; Accepted 18 June 2013

Academic Editor: Akinori Nakamura

Copyright © 2013 Yoshitsugu Aoki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Yoshitsugu Aoki, Toshifumi Yokota, and Matthew J. A. Wood, “Development of Multiexon Skipping Antisense Oligonucleotide Therapy for Duchenne Muscular Dystrophy,” BioMed Research International, vol. 2013, Article ID 402369, 8 pages, 2013. doi:10.1155/2013/402369